GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Andros Pharmaceuticals Co Ltd (ROCO:6917) » Definitions » Pre-Tax Income

Andros Pharmaceuticals Co (ROCO:6917) Pre-Tax Income : NT$-76.11 Mil (TTM As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Andros Pharmaceuticals Co Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Andros Pharmaceuticals Co's pretax income for the six months ended in Jun. 2024 was NT$-32.38 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2024 was NT$-76.11 Mil. Andros Pharmaceuticals Co's pretax margin was -43,760.81%.

During the past 5 years, Andros Pharmaceuticals Co's highest Pretax Margin was -278.74%. The lowest was -38627.89%. And the median was -2403.68%.


Andros Pharmaceuticals Co Pre-Tax Income Historical Data

The historical data trend for Andros Pharmaceuticals Co's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Andros Pharmaceuticals Co Pre-Tax Income Chart

Andros Pharmaceuticals Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
-56.78 -35.86 -37.11 -41.18 -68.14

Andros Pharmaceuticals Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only -19.00 -22.17 -24.41 -43.73 -32.38

Competitive Comparison of Andros Pharmaceuticals Co's Pre-Tax Income

For the Biotechnology subindustry, Andros Pharmaceuticals Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Andros Pharmaceuticals Co's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Andros Pharmaceuticals Co's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Andros Pharmaceuticals Co's Pre-Tax Income falls into.



Andros Pharmaceuticals Co Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Andros Pharmaceuticals Co's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-73.71+0+-0.44+4.371+1.642
=-68.14

Andros Pharmaceuticals Co's Pretax Income for the quarter that ended in Jun. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-38.147+0+-0.179+3.215+2.728
=-32.38

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-76.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Andros Pharmaceuticals Co  (ROCO:6917) Pre-Tax Income Explanation

Andros Pharmaceuticals Co's Pretax Margin for the quarter that ended in Jun. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-32.383/0.074
=-43,760.81%

During the past 5 years, Andros Pharmaceuticals Co's highest Pretax Margin was -278.74%. The lowest was -38627.89%. And the median was -2403.68%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Andros Pharmaceuticals Co Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Andros Pharmaceuticals Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Andros Pharmaceuticals Co Business Description

Traded in Other Exchanges
N/A
Address
No. 22, Sec. 2, Shengyi Road, 6th Floor, Building D, Biotech Building, Hsinchu Biomedical Science Park, Hsinchu County, Zhubei City, TWN, 30261
Andros Pharmaceuticals Co Ltd is a biopharmaceutical company engaged in developing novel drug delivery platform technologies. The firm focuses on the development of topical new dosage forms and non-viral gene delivery systems, with the current pipeline indicated for pain management, DNA repair, and gene therapy. Its product line comprises New Dosage Forms (Topical), Super Generics (Topical), High-End Cosmetic Ingredients (Topical), and Gene Delivery Systems (Injectable).

Andros Pharmaceuticals Co Headlines

No Headlines